Androgens and fetal growth

F de Zegher1, I Francois, A L Boehmer

  • 1University of Leuven, Belgium.

Hormone Research
|December 5, 1998
PubMed

Insights

Male infants are typically heavier than female infants at birth. However, boys with androgen insensitivity syndrome have birth weights similar to girls, suggesting androgens influence sex-based weight differences.

Area of Science:

  • Endocrinology
  • Human Genetics
  • Reproductive Biology

Background:

  • Sexual dimorphism in birth weight is a well-documented phenomenon.
  • The role of androgens in mediating sex differences during fetal development is not fully elucidated.
  • Androgen insensitivity syndrome (AIS) presents a unique model to study androgen action.

Purpose of the Study:

  • To investigate the impact of androgen action on fetal growth and birth weight.
  • To determine if androgen insensitivity syndrome affects birth weight in 46,XY individuals.
  • To test the hypothesis that androgens contribute to the observed sex difference in birth weight.

Main Methods:

  • Retrospective analysis of birth weights in a cohort of children with 46,XY karyotype.
  • Comparison of birth weights between typically developing males, typically developing females, and individuals with androgen insensitivity syndrome.
  • Genetic analysis to confirm mutations in the androgen receptor gene in AIS cases.

Main Results:

  • Children with 46,XY karyotype and complete androgen insensitivity syndrome exhibited birth weights comparable to those of girls.
  • This finding was observed in cases with both clinically complete AIS and confirmed androgen receptor gene mutations.
  • Typically developing boys were heavier than typically developing girls at term birth.

Conclusions:

  • Androgen action plays a significant role in establishing the sex difference in birth weight.
  • The absence of functional androgen signaling in 46,XY individuals normalizes their birth weight to female ranges.
  • These findings strongly support the hypothesis that androgens are a key determinant of sex-specific fetal growth patterns.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Development of the Sexual Organs in the Embryo and Fetus01:15

Development of the Sexual Organs in the Embryo and Fetus

Development of the reproductive organs in an embryo starts from a bipotential state. This means the early embryo can develop either male or female reproductive organs. The formation of these organs begins with the growth of gonadal ridges that arise from the intermediate mesoderm during the fifth week of development.
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the male...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...